Navigation Links
Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
Date:9/17/2008

CRANBURY, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), today announced that President and Chief Executive Officer John F. Crowley will make a presentation at the UBS Global Life Sciences Conference on Wednesday, September 24, 2008, at 10:30 a.m. EDT in New York.

An audio webcast of the presentation will be available at the Amicus Web site at http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the webcast. An audio replay of the webcast will also be available on the Company's Web site for 30 days until October 24, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amicus Therapeutics Opens Research Facility in San Diego
2. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
3. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
4. Amicus Therapeutics Announces First Quarter 2008 Financial Results
5. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
6. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
7. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
10. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
11. Amicus Therapeutics to Host R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... “Preparative & Process Chromatography Market by ... Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End ... to 2019” provides a detailed overview of the ... and strategies impacting the preparative and process chromatography ... the revenue and share analysis. , Full ...
(Date:12/24/2014)... Island, New York (PRWEB) December 23, 2014 ... and the Long Island Affiliate of ITRA Global, the national ... slow but steady recovery. This is evidenced by the ... the strong stock market. Low energy costs have held ... The only negative is the housing market remaining soft. ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
Breaking Biology Technology:Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... LifeQuest World Corporation,(OTC Bulletin Board: LQWC) is ... work, ImmunXT, their Immune System enhancement supplement, has,been ... as of March 2008.,ImmunXT has been proclaimed as ... ImmunXT (US Patent #7,205,284 B2),is a bio-active Micro-algae ...
... (OTC Bulletin Board: GNTA) announced today that it ... (FINRA, formerly,the NASD) has cleared a market maker,s ... the Over-the-Counter Bulletin Board (OTCBB). As a,result, the ... Company,s,common stock will begin on Wednesday, May 7, ...
... Calif., May 6 Kosan Biosciences,Incorporated (Nasdaq: ... Vice,President, Corporate Communications, will present at the Leerink ... the Grand Hyatt Hotel on,Friday, May 9, 2008 ... the presentation,can be accessed through http://www.wsw.com/webcast/leerink15/kosn/ ., ...
Cached Biology Technology:LifeQuest World Launches Immune System Boosting Supplement to the North American Market 2Genta Announces Transfer of its Common Stock to the OTC Bulletin Board 2Genta Announces Transfer of its Common Stock to the OTC Bulletin Board 3Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference 2
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... gene therapy reversed course of disease in mouse modelsIn ... disease, scientists were able to reverse the rodents' memory ... is crucial for the development of Alzheimer's disease. , ... that stopping the synthesis of a protein that is ...
... Billions of people tuned into recent Live 8 concert ... the altruistic cause spearheaded by former Boomtown Rat, Sir ... of us look out for each other, while others ... natural selection has designed individuals to behave selfishishly; selfish ...
... medically important fungus, causing potentially life-threatening infections in patients ... cause of respiratory allergy, and it is implicated in ... to lack the ability to reproduce sexually, but new ... the fungus has a number of characteristics of sex. ...
Cached Biology News:Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models 2Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models 3Helping in a selfish world 2Secret sex life of killer fungus? 2
Recombinant Rat Leptin, CF...
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Gamma Globulin (BGG) through lysine by amide bonds....
... 25 mL pipets ,Angled acrylic pipet rack offers ... or round pipet cans. Constructed of 6 mm (1/4 ... W x 76 mm H x 289 mm D ... 89 mm W x 406 mm H x 292 ...
... Contact Printing Kit contains choice of PDMS ... of 100 / 200 micron squares or ... um x 10 mm lines, 3 PDMS ... or 60 nm and pitch of 400 ...
Biology Products: